Please login to the form below

Not currently logged in


This page shows the latest Artesunate news and features for those working in and with pharma, biotech and healthcare.

Sanofi ships synthetic malaria jab

Sanofi ships synthetic malaria jab

Artesunate - the active ingredient produced from semisynthetic artemisinin - and semisynthetic artemisinin itself are identical to those derived from the natural world. ... The drugs were manufactured with semisynthetic artesunate in Morocco and are

Latest news

  • S-A agrees malaria research project

    sub-Saharan Africa concerning the safety and efficacy of anti-malarial drug artesunate-amodaquine.

  • CSR in action

    It is the largest study ever conducted in sub-Saharan Africa into the safety and efficacy of our anti-malarial drug artesunate-amodaquine.

  • S-A wins award for malaria programme

    The Malaria Access to Medicines Programme has seen S-A and not-for-profit product developers, DNDi, develop and distribute anti-malarial treatment, Coarsucam, or ASAQ (artesunate amodiaquine winthrop) in the

  • R & D news in brief

    The study, published in the Lancet and funded by the Wellcome Trust, found that artesunate, a derivative of artemisinin, reduced mortality by 35 per cent in comparision with quinine. ... Study chief, Professor Nick White, said artesunate was easier to

  • Pharma news in brief

    and Drug Administration or the European Medicines Agency (EMEA), for its new malaria combination (artesunate-amodiaquine) product.

More from news
Approximately 0 fully matching, plus 6 partially matching documents found.

Latest Intelligence

  • Interview: Charles Mgone, EDCTP Interview: Charles Mgone, EDCTP

    simplification of intravenous Artesunate treatment of severe childhood malaria; early studies on novel anti-TB vaccines and the establishment of networks for conducting clinical trials.

More from intelligence
Approximately 0 fully matching, plus 1 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs


Add my company
Six Degrees Medical Consulting

For over a decade, our medical communication services have helped pharmaceutical companies optimize their brand, disease and corporate objectives. Building...

Latest intelligence

Virtual meeting technologies for reducing emissions and waste in the healthcare industry
Diversity in clinical trials: looking back at our 2021 blogs
In this blog, we look back at the Innovative Trials' Equality & Diversity (E&D) committee blogs across 2021...
What does the future hold for Light-chain Amyloidosis?
Recent advances in the understanding and treatment are reforming pharma’s approach to the management of this rare disease. With a new standard of care rapidly developing, what does the landscape...